M MS 100 Pill - gray round, 10mm
Pill with imprint M MS 100 is Gray, Round and has been identified as Morphine Sulfate Extended Release 100 mg. It is supplied by Mylan Pharmaceuticals Inc.
Morphine is used in the treatment of Chronic Pain; Neonatal Abstinence Syndrome; Pain and belongs to the drug class Opioids (narcotic analgesics). Risk cannot be ruled out during pregnancy. Morphine 100 mg is classified as a Schedule 2 controlled substance under the Controlled Substance Act (CSA).
Images for M MS 100
Morphine Sulfate Extended Release
- Imprint
- M MS 100
- Strength
- 100 mg
- Color
- Gray
- Size
- 10.00 mm
- Shape
- Round
- Availability
- Prescription only
- Drug Class
- Opioids (narcotic analgesics)
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- 2 - High potential for abuse
- Labeler / Supplier
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC)
- 00378-2661 (Discontinued)
- Inactive Ingredients
-
silicon dioxide,
lactose monohydrate,
magnesium stearate,
magnesium silicate,
titanium dioxide,
FD&C Blue No. 2,
ferric oxide red,
ferric oxide yellow
Note: Inactive ingredients may vary.
Related images for "M MS 100"
More about morphine
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (366)
- Drug images
- Latest FDA alerts (12)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: Opioids (narcotic analgesics)
- Breastfeeding
Patient resources
- Morphine drug information
- Morphine injection
- Morphine (Epidural) (Advanced Reading)
- Morphine Extended-Release Capsules
- Morphine Immediate-Release Tablets and Capsules
Other brands
MS Contin, Kadian, MorphaBond ER, Roxanol, ... +10 more
Professional resources
- Morphine Sulfate monograph
- Morphine ER (FDA)
- Morphine Extended Release Capsules (FDA)
- Morphine Injection (FDA)
- Morphine Oral Solution (FDA)
Other brands
MS Contin, Kadian, MorphaBond ER, Duramorph, ... +4 more
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.